
Tommaso Barba
@tommaso_barba
PhD candidate at the Centre for Psychedelic Research, Imperial College London 🧠 🍄 // [email protected] @Imperial_PRG @imperialcollege
ID: 1514734140742156300
14-04-2022 22:35:56
1,1K Tweet
4,4K Followers
439 Following

Great news and yet another significant step forward for psychedelic medicine! Today, atai Life Sciences and Beckley Psytech announced (very!) positive topline results from the long-awaited Phase 2b trial of a single dose of BPL‑003 (5-MeO-DMT) in 193 patients living with


Ok I've basically been entirely off social media and returning here it is overrwhelmingly abundantly and profoundly clear that this place - and all of these places - are a poison - a prison of utterly short form deep sounding nonsense attached to no one that ur brain will discard

1/🚨 Interesting and surprising animal data was just published in npj Journals on psilocybin’s geroprotective (lifespan extension) potential 🍄 → +51% increase in fibroblast lifespan (in vitro) → Monthly "low-dose" psilocybin (5–15 mg/kg) doubled survival in aged mice →









Nicholas Fabiano, MD Yes! And you need the attention to stay with it. Meditation strengthens the networks that hold focus under stress (DLPFC, ACC, insula). One study cut burnout + depression by nearly a full effect size. So purpose gets you moving. And mindfulness keeps you aligned.








